SGRY logo

SURGERY PARTNERS INC

SGRYNASDAQ
πŸ† #1411 by market capEarnings Nov 9 Β· PreUS Equity
$15.02β–Ό $0.87 (βˆ’5.77%)
Live
1hβ€”
24hβ–Ό 5.8%
7dβ–Ό 4.0%
14dβ–Ό 3.6%
30dβ–Ό 8.3%
1yβ–Ό 34.0%
🏦Market Cap
$1.96B
Small Cap
πŸ“ˆRevenue Growth (YoY)
-20.5%
Declining
πŸ“ŠGross Margin
25.2%
Moderate
πŸ’΅FCF Margin
8.4%
Moderate
βš–οΈP/S Ratio
0.9x
Cheap
Otter Score
47
Weak

Trading Snapshot

Day Range
$14.85 – $15.17
52-Week Range
$11.41 – $24.10
Volume
$5.66B
Avg Volume
$5.83B
Shares Outstanding
130.8M
Next Earnings
Sep 11, 2026

Fundamentals Snapshot

Annual Revenue
$2.53B
Last Q Revenue
$587M
P/E Ratio
β€”
P/S Ratio
0.9x
EPS (TTM)
$-0.61
Dividend Yield
β€”

Why Investors Own SGRY

  • βœ“High-growth profile β€” revenue up +0.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 48% gross margin and 17% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$2.53Bβ–Ό βˆ’3.1% YoY
Gross Margin (TTM)
47.6%β–² +3.9% YoY
Operating Income (TTM)
$351Mβ–Ό βˆ’3.1% YoY
Free Cash Flow (TTM)
$437Mβ–Ό βˆ’3.1% YoY

About SURGERY PARTNERS INC

A company profile for SURGERY PARTNERS INC isn’t available yet β€” check back soon.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
47/100

Analyst Ratings

β“˜
Consensus
Buy
18 analysts
Strong Buy5
Buy9
Hold4
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates